Goldman Sachs Group Inc Takeda Pharmaceutical CO LTD Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,500,965 shares of TAK stock, worth $65.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,500,965
Previous 5,320,793
15.41%
Holding current value
$65.7 Million
Previous $79.1 Million
12.05%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding TAK
# of Institutions
370Shares Held
73MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$194 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$111 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$58.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$54.2 Million0.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.3MShares$48.2 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...